user

Pembrolizumab in Triple-Negative Breast Cancer

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] MKA Breast Canc Clin, Ankara, Turkey
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 387卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1435 / 1436
页数：2
相关论文
共 50 条
  • [1] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [2] Pembrolizumab for Early Triple-Negative Breast Cancer
    Schmid, Peter
    Cortes, Javier
    Pusztai, Lajos
    McArthur, Heather
    Kuemmel, Sherko
    Bergh, Jonas
    Denkert, Carsten
    Park, Yeon Hee
    Hui, Rina
    Harbeck, Nadia
    Takahashi, Masato
    Foukakis, Theodoros
    Fasching, Peter A.
    Cardoso, Fatima
    Untch, Michael
    Jia, Liyi
    Karantza, Vassiliki
    Zhao, Jing
    Aktan, Gursel
    Dent, Rebecca
    O'Shaughnessy, Joyce
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 810 - 821
  • [3] Pembrolizumab and atezolizumab in triple-negative breast cancer
    Kwapisz, Dorota
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 607 - 617
  • [4] Pembrolizumab and atezolizumab in triple-negative breast cancer
    Dorota Kwapisz
    Cancer Immunology, Immunotherapy, 2021, 70 : 607 - 617
  • [5] Pembrolizumab for Early Triple-Negative Breast Cancer
    Cetin, Bulent
    Gumusay, Ozge
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26):
  • [6] Pembrolizumab in Triple-Negative Breast Cancer Reply
    Cortes, Javier
    Zhou, Xuan
    Schmid, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1436 - 1436
  • [7] Pembrolizumab monotherapy in metastatic triple-negative breast cancer
    Amir, Eitan
    Cescon, David W.
    LANCET ONCOLOGY, 2021, 22 (04): : 415 - 417
  • [8] Pembrolizumab plus Chemotherapy for triple-negative Breast Cancer
    Judith Lorenz, Kuenzell
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (11) : 1114 - 1114
  • [9] Pembrolizumab in Early Triple-Negative Breast Cancer Reply
    Schmid, Peter
    Cortes, Javier
    Dent, Rebecca
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1771 - 1772
  • [10] Pembrolizumab for Early Triple-Negative Breast Cancer Reply
    Schmid, Peter
    Dent, Rebecca
    O'Shaughnessy, Joyce
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26):
12345